Tegenero AG
Wuerzburg, DE· latest recorded location
Tegenero AG is named on 2 US grants and 5 published applications in this corpus. Its most frequent classification is A61P (Therapeutic uses of medicines).
- Granted patents
- 2
- Published applications
- 5
- Inventors
- 7
- Granted in 2026 so far
- 0
- Most recent grant
- 19 Nov 2013
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2006 | 1 | 2 |
| 2007 | 0 | 0 |
| 2008 | 0 | 0 |
| 2009 | 0 | 1 |
| 2010 | 0 | 1 |
| 2011 | 0 | 1 |
| 2012 | 0 | 0 |
| 2013 | 1 | 0 |
By publication year.
Technology areas
Share of 7 documents
Recent patents
- Peptide or protein comprising a C′-D loop of the CD28 receptor family19 Nov 2013US 8,586,386 B2
- Human CD28 specific monoclonal antibodies for antigen-non-specific activation of T-lymphocytes17 Jan 2006US 6,987,171 B1
- Peptide or protein comprising a c'-d loop of the cd28 receptor family3 Mar 2011US 2011/0052587 A1
- Use of a cd28 binding pharmaceutical substance for making a pharmaceutical composition with dose-dependent effect21 Oct 2010US 2010/0266605 A1
- Use of a cd28 binding substance for making a pharmaceutical composition1 Oct 2009US 2009/0246204 A1
- Superagonistic anti-CD28 antibodies21 Dec 2006US 2006/0286104 A1
- Use of an active substance that binds to cd28 for producing a pharmaceutical composition24 Aug 2006US 2006/0188493 A1
Most cited
By later US patents